Physician profile
Mary K Downs
NPI 1750300794
$16,899.19
in general payments reported to CMS, 2019-2025
63 companies · $3,500 in 2025
The $3,500 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,372 · 2020: $944 · 2021: $1,581 · 2022: $2,393 · 2023: $3,083 · 2024: $3,026 · 2025: $3,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,272 · Education: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,272.06 |
| Education | $336.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $2,001.57 | 2019-2025 | Mavenclad, Mavenclad |
| Neurocrine Biosciences, INC. | $1,242.43 | 2019-2025 | Ingrezza, Ongentys |
| Ucb, INC. | $1,143.91 | 2020-2025 | Fintepla, Rystiggo, Briviact |
| Abbvie INC. | $1,142.09 | 2021-2025 | Ubrelvy, Qulipta |
| Biogen, INC. | $1,013.42 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Teva Pharmaceuticals USA, INC. | $851.17 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Sk Life Science, INC. | $714.61 | 2021-2025 | Xcopri |
| Novartis Pharmaceuticals Corporation | $681.41 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $646.52 | 2019-2025 | Ultomiris, Soliris, Koselugo |
| Tg Therapeutics, INC. | $601.19 | 2024-2025 | |
| Amgen INC. | $595.14 | 2019-2025 | Uplizna |
| Genzyme Corporation | $528.80 | 2019-2025 | |
| Lundbeck LLC | $481.92 | 2019-2025 | Vyepti, Rexulti |
| Neurelis, INC. | $465.71 | 2021-2025 | Valtoco |
| Celgene Corporation | $413.04 | 2019-2025 | Zeposia |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Downs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.